A model‐based meta analysis study of sodium glucose co‐transporter‐2 inhibitors

Type 2 diabetes mellitus (T2DM) agent sodium‐glucose co‐transporter 2 (SGLT2) inhibitors show special benefits in reducing body weight and heart failure risks. To accelerate clinical development for novel SGLT2 inhibitors, a quantitative relationship among pharmacokinetics, pharmacodynamics, and dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Xueting, Zhou, Jiawei, Song, Ling, Ren, Yupeng, Hu, Pei, Liu, Dongyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088079/
https://www.ncbi.nlm.nih.gov/pubmed/36890732
http://dx.doi.org/10.1002/psp4.12934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088079/
https://www.ncbi.nlm.nih.gov/pubmed/36890732
http://dx.doi.org/10.1002/psp4.12934

Ejemplares similares